Seattle, USA; Amsterdam, Netherlands; London, UK, 14 Aug 2006 – Fred Hutchinson Cancer Research Center, The Netherlands Cancer Institute (NKI) and Cancer Research Technology Limited (CRT) today have released details of the development and commercialisation of a powerful protein-genome interaction mapping technology termed ‘DamID.’
